Showing 9381-9390 of 18069 results for "".
- Targeting Programmed Cell Death in Inflammatory Bowel Diseasehttps://reachmd.com/news/targeting-programmed-cell-death-in-inflammatory-bowel-disease/2475438/Although biologics and small molecules have expanded our options, many patients with inflammatory bowel disease continue to suffer from refractory inflammation and mucosal injury because current treatments often overlook underlying cellular d
- Artificial Intelligence in Myopia: Detection, Prediction, and Future Challengeshttps://reachmd.com/news/artificial-intelligence-in-myopia-detection-prediction-and-future-challenges/2475412/As myopia surges toward becoming a global health crisis—with projections suggesting nearly half the world’s population will be affected by 2050—researchers are turning to artificial intelligence (AI) as a critical tool in the early detection, risk assessment, and lo
- Maximizing Survival in Stage IV HER2-Positive Gastric Cancer: The Role of Conversion Surgeryhttps://reachmd.com/news/maximizing-survival-in-stage-iv-her2-positive-gastric-cancer-the-role-of-conversion-surgery/2475426/Conversion surgery, a procedure intended to convert unresectable tumors to resectable ones, may be underutilized for patients with Stage IV HER2-positive gastric cancer, potentially due to various clinical and economic factors affecting decis
- Navigating Challenges and Innovations in Robotic-Assisted Spine Surgeryhttps://reachmd.com/news/navigating-challenges-and-innovations-in-robotic-assisted-spine-surgery/2475433/Robotic-assisted spine surgery offers enhanced precision for orthopedic surgeons but also introduces specific challenges that require careful management. Despite the precision offered by robotic systems, they introduce specific complic
- Evolving Impact of Public Opinion on Childhood Vaccination Policieshttps://reachmd.com/news/evolving-impact-of-public-opinion-on-childhood-vaccination-policies/2475425/Robust public support is actively reshaping childhood vaccination policies, with rising concern over measles underscoring the public’s influence on policy decisions. Public health officials and pediatricians face a persistent challenge
- Innovations in Obesity Management: The Clinical Impact of Tirzepatidehttps://reachmd.com/news/innovations-in-obesity-management-the-clinical-impact-of-tirzepatide/2475403/Although global obesity rates continue to rise, innovative pharmacological agents such as tirzepatide are capturing clinical attention for their ability to suppress appetite and drive substantial weight loss, complementing existing lifestyle
- Novel Biomarkers for Early Detection and Intervention in Psychosis and Depressionhttps://reachmd.com/news/novel-biomarkers-for-early-detection-and-intervention-in-psychosis-and-depression/2475398/Exploring novel biomarkers for early detection and improved intervention in psychosis and depression, recent data highlight grip strength and inflammatory profiles as windows into psychiatric pathophysiology. Distinguishing incipient p
- Evolving Strategies in Obesity Care: Integrating Holistic and Innovative Approacheshttps://reachmd.com/news/evolving-strategies-in-obesity-care-integrating-holistic-and-innovative-approaches/2475399/Evolving Strategies in Obesity Care: Integrating Holistic and Innovative Approaches With over 40% of US adults classified as obese, clinicians are rethinking strategies that focus exclusively on weight reduction, embra
- High Defect Rate of Cancer Medications in Sub-Saharan Africa: Urgent Need for Innovative Solutionshttps://reachmd.com/news/high-defect-rate-of-cancer-medications-in-sub-saharan-africa-urgent-need-for-innovative-solutions/2475404/The high defect rate of cancer medications in sub-Saharan Africa is directly impacting patient outcomes and safety, demanding urgent attention and innovative responses. Research from the University of Notre Dame highlights that 1 in 6
- The Evolving Role of JAK Inhibitors: Upadacitinib’s Impact on Giant Cell Arteritishttps://reachmd.com/news/the-evolving-role-of-jak-inhibitors-upadacitinibs-impact-on-giant-cell-arteritis/2475405/Upadacitinib, a Janus kinase (JAK) inhibitor, has shown efficacy in managing giant cell arteritis by achieving sustained remission in clinical trials, potentially providing an alternativ